SCHEMBL5190427

SCHEMBL5190427

COC(=O)CN1CCC(O)(CN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1

nearest known ligand 0.49

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ CCR3 P51677 19/20 0.49
▸ HRH1 P35367 19/20 0.46
▸ KCNH2 Q12809 15/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5190405 0.89 HRH1 (0.51) CCR3HRH1KCNH2
SCHEMBL5191284 0.83 HRH1 (0.65) CCR3HRH1KCNH2
SCHEMBL4966177 0.81 CCR3 (0.59) CCR3HRH1KCNH2
SCHEMBL5194646 0.80 CCR3 (0.47) CCR3HRH1KCNH2
SCHEMBL5191295 0.80 CCR3 (0.47) CCR3HRH1KCNH2
SCHEMBL5191328 0.77 HRH1 (0.72) CCR3HRH1KCNH2
SCHEMBL4967102 0.77 HRH1 (0.72) CCR3HRH1KCNH2
SCHEMBL5192663 0.77 HRH1 (0.61) CCR3HRH1KCNH2
SCHEMBL5363961 0.77 CCR3 (0.59) CCR3HRH1KCNH2
SCHEMBL5194895 0.77 CCR3 (0.57) CCR3HRH1KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1816123-A1 Intermediates for the production of pharmaceutically active compounds AstraZeneca AB (SE) 2007-08-08 — — EP disclosed
EP-1546130-B1 PIPERIDINE DERIVATIVES FOR USE IN THE TREATMENT OF CHEMOKINE MEDIATED DISEASE STATES ASTRAZENECA AB (SE) 2007-08-01 — — EP disclosed
Send feedback